Vaccines company Valneva said on Thursday that its inactivated COVID-19 vaccine candidate product VLA2001 had its shelf life extended to 21 months from 18 months previously, as it unveiled regulatory updates for the product.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.